Buprenorphine/Naloxone

@article{Orman2012BuprenorphineNaloxone,
  title={Buprenorphine/Naloxone},
  author={Jennifer S. Orman and Gillian M. Keating},
  journal={Drugs},
  year={2012},
  volume={69},
  pages={577-607}
}
SummaryAbstractBuprenorphine/naloxone (Suboxone®) comprises the partial μ-opioid receptor agonist buprenorphine in combination with the opioid antagonist naloxone in a 4: 1 ratio. When buprenorphine/naloxone is taken sublingually as prescribed, the naloxone exerts no clinically significant effect, leaving the opioid agonist effects of buprenorphine to predominate. However, when buprenorphine/naloxone is parenterally administered in patients physically dependent on full agonist opioids, the… Expand
Buprenorphine/Naloxone (Zubsolv®): A Review in Opioid Dependence
TLDR
Buprenorphine/naloxone was generally well tolerated, displaying a tolerability profile that was generally consistent with that seen with reference buprenorphins, and expands the treatment options available for adults and adolescent patients with opioid dependence. Expand
Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial.
TLDR
This preliminary trial investigated the feasibility of using naltrexone to facilitate buprenorphine discontinuation in stable individuals who had tolerated a taper to 2mg or less but were unable to terminate entirely due to withdrawal-related distress. Expand
Buprenorphine/naloxone addiction in a pharmacist as a result of migraine self-treatment
TLDR
A 35-year-old female hospital pharmacist was admitted to treatment for opioid use disorder for using buprenorphine/naloxone film to self-medicate her migraine headaches and maintains sobriety at the treatment center. Expand
Urine naloxone concentration at different phases of buprenorphine maintenance treatment.
TLDR
It is suggested that naloxone in urine can act as an indicator of compliance with BNX, and the use/abuse of buprenorphine alone. Expand
Effects of a higher-bioavailability buprenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter, randomized trial.
TLDR
The findings suggest that BNX sublingual tablets are an efficacious and well-tolerated option for induction and early stabilization treatment of opioid dependence. Expand
Patients that benefit from buprenorphine-naloxone on medically assisted treatment for opioid dependence in Malaysia.
TLDR
Buprenorphine-naloxone is a safe and effective drug substitution therapy for opioid dependence that has fewer interactions with other medications, and has similar efficacy to methadone. Expand
Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals
TLDR
Methadone/lofexidine and buprenorphine/naloxone had comparable outcomes during rapid outpatient stabilisation and detoxification in low dose opiate users. Expand
Concomitant drugs with buprenorphine user deaths.
TLDR
The unprecedentedly high concomitant use of benzodiazepines in buprenorphine user deaths obscures other possible pharmacological risk factors for bup Renorphine poisoning that could be relevant for prevention. Expand
Oxycodone/Naloxone Prolonged-Release: A Review of Its Use in the Management of Chronic Pain While Counteracting Opioid-Induced Constipation
TLDR
Although more comparative data are needed, oxycodone/naloxone PR is an effective option for use in patients with severe chronic pain, particularly among those with opioid-induced constipation. Expand
Buprenorphine analogue BU08028 is one step closer to the Holy Grail of opioid research
  • Jun-Xu Li
  • Medicine
  • Proceedings of the National Academy of Sciences
  • 2016
TLDR
A systematic evaluation of a novel opioid, BU08028, which may lead research one step closer to the “Holy Grail” of opioid analgesic research: the development of opioids that retain the analgesic efficacy with reduced side effects. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 106 REFERENCES
Effects of buprenorphine/naloxone in opioid-dependent humans
TLDR
Intramuscular injection of buprenorphine/naloxone precipitates withdrawal in opioid dependent persons; therefore, the combination has a low abuse potential by the injection route in this population. Expand
Blockade of hydromorphone effects by buprenorphine/naloxone and buprenorphine
TLDR
The addition of naloxone to buprenorphine may deter the parenteral abuse of bupRenorphine/nalox one, but it does not enhance the therapeutic efficacy of bu prenorphines. Expand
Buprenorphine and naloxone interactions in methadone maintenance patients
TLDR
The physiologic and subjective effects of intravenously administered buprenorphine and naloxone given alone and in combination to methadone-maintained patients (40-60 mg/day) are described. Expand
Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin-dependent volunteers
TLDR
These data demonstrate that both 8/2 and 32/8 mg buprenorphine/naloxone were well tolerated and effective in reducing the reinforcing and subjective effects of heroin, relative to the 2/0.5-mg dose, and show for the first time in humans that it is possible to quantify the efficacy and affinity of heroin for mu opioid receptors. Expand
Buprenorphine-Containing Treatments
TLDR
Because of its relative safety and lower risk of illegal diversion, buprenorphine has been made available in several countries for treating opioid addiction in the private office setting, greatly enhancing treatment options for this condition. Expand
Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts.
TLDR
The combination of buprenorphine with naloxone in a 4:1 ratio produced opioid antagonist-like effects which should limit its potential for intravenous abuse by opioid addicts. Expand
Buprenorphine: how to use it right.
TLDR
The buprenorphine plus naloxone combination product should provide additional safeguards for use in office-based practice by decreasing risk of diversion, and office- based treatment should expand the availability of services to opioid dependent patients. Expand
Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
TLDR
It is indicated that buprenorphine maintenance produces physical dependence and that i.m. naloxone and p.o. naltrexone produce equivalent effects in withdrawal precipitation under these conditions. Expand
Effects of buprenorphine and methadone in methadone-maintained subjects
TLDR
It is suggested that abrupt transition from methadone to buprenorphine may produce patient discomfort that is positively related to both methad one maintenance dose and bupenorphine transition dose. Expand
Buprenorphine and naloxone alone and in combination in opioid-dependent humans
TLDR
Overall, the naloxone-buprenorphine combinations produced effects which were qualitatively similar to the effects of n aloxone alone, suggesting a low potential for abuse of the combination product by opioid-dependent individuals. Expand
...
1
2
3
4
5
...